In Vitro Activity of U-76,252 (CS-807), a New Oral Cephalosporin
Overview
Authors
Affiliations
U-76,252 is the prodrug of U-76,253. MICs of U-76,253 were 0.015 to 0.06 microgram/ml for greater than or equal to 90% of the strains of Streptococcus spp., Haemophilus influenzae, and Proteus mirabilis; 0.25 to 1 microgram/ml for Branhamella catarrhalis, Escherichia coli, Klebsiella spp., and Citrobacter diversus; 1 to 8 micrograms/ml for Staphylococcus spp.; and 2 to greater than 16 micrograms/ml for other members of the family Enterobacteriaceae and Aeromonas hydrophila; for 72% of the latter group, MICs were less than or equal to 4 micrograms/ml. MICs for Pseudomonas aeruginosa and Enterococcus faecalis were greater than 16 micrograms/ml.
Takasugi N, Tsunaga N, Sugino N, Numa F, Kato H Antimicrob Agents Chemother. 1996; 40(8):1832-4.
PMID: 8843289 PMC: 163425. DOI: 10.1128/AAC.40.8.1832.
Johnson C, Ateshkadi A, Zimmerman S, Hughes G, Craig W, Carey P Antimicrob Agents Chemother. 1993; 37(12):2650-5.
PMID: 8109931 PMC: 192767. DOI: 10.1128/AAC.37.12.2650.
Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.
Knapp C, Sierra-Madero J, Washington J Antimicrob Agents Chemother. 1988; 32(12):1896-8.
PMID: 3245701 PMC: 176041. DOI: 10.1128/AAC.32.12.1896.
Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporin.
Neu H, Saha G, Chin N Antimicrob Agents Chemother. 1989; 33(10):1795-800.
PMID: 2589845 PMC: 172757. DOI: 10.1128/AAC.33.10.1795.
Cefpodoxime proxetil in patients with endstage renal failure on hemodialysis.
Hoffler D, Koeppe P, Corcilius M, Przyklinik A Infection. 1990; 18(3):157-62.
PMID: 2365467 DOI: 10.1007/BF01642104.